- freely available
Int. J. Mol. Sci. 2013, 14(7), 13129-13136; doi:10.3390/ijms140713129
Published: 25 June 2013
Abstract: The aim of our study was to evaluate the diagnosis of desmoplastic reaction (DR) by immunostaining for α-smooth muscle actin (αSMA) and desmin, for predicting the depth of submucosal invasion in biopsy specimens of early colorectal carcinomas (CRCs). Thirty-eight cases of non-pedunculated early CRCs were included in this study. Positive for DR was defined as αSMA-positive and desmin-negative stroma in the CRC. The depth of submucosal invasion was measured in endoscopically or surgically resected specimens and the lesions were subsequently divided into two groups: Group A (carcinoma in situ/intramucosal carcinoma and submucosal invasive carcinoma with a depth <1000 μm) and Group B (submucosal invasion with a depth ≥1000 μm). Twenty-one cases were DR-positive and 17 were DR-negative. No statistical significance was found between the DR with regard to tumor size, location and histological type. All DR-positive cases belonged to Group B whereas 14 (82.4%) DR-negative lesions belonged to Group A (p < 0.001). The sensitivity, specificity, positive and negative predictive values and accuracy of DR positivity for diagnosis of Group B were 87.5%, 100%, 100%, 82.4% and 92.1%, respectively. Conclusively, detection of DR in biopsy specimens with ancillary immunohistochemistry (αSMA/desmin) would help in preoperative diagnosis for the depth of submucosal invasion of early CRC.
Early colorectal carcinomas (CRCs) were classified into three groups: M, carcinoma in situ and intramucosal carcinoma; SM1, submucosal invasive carcinoma with a depth of less than 1000 μm; and SM2, submucosal invasive carcinoma with a depth of greater than or equal to 1000 μm . We previously demonstrated a relationship between the depth of submucosal invasion (SM depth) and the frequency of lymph node metastasis in resected early CRCs . Endoscopic resection, including polypectomy, endoscopic resection and endoscopic submucosal dissection may be applied for M CRCs , pedunculated SM CRCs diagnosed as head invasion , and non-pedunculated SM1 CRCs [2,5]. Conversely, SM2 CRCs show lymph node metastasis in 10 to 15% of cases, and surgical resection accompanied by lymph node dissection is recommended . The rate of lymph node metastasis is not thought to be related to SM depth in SM2 CRC . Thus, discrimination between M/SM1 CRC (Group A) and SM2 CRC (Group B) is very important for selecting therapeutic modalities against SM CRC. We also previously reported that the detection of desmoplastic reaction (DR) in pretreatment biopsy specimens was useful for predicting the SM depth in non-pedunculated, but not in pedunculated SM CRCs [1,6]. In these studies, DR was evaluated by hematoxylin and eosin (H&E) staining of the biopsy specimens, although it was difficult to diagnose DR in some cases of pedunculated CRCs .
The aim of the present study was to evaluate the diagnosis of DR by immunostaining for α-smooth muscle actin (αSMA) and desmin for discriminating Group A from Group B in biopsy specimens of early CRCs.
2. Results and Discussion
2.1.1. Clinicopathological Features
Thirty-eight out of 51 (74.5%) early CRCs were of the non-pedunculated type and 13 (25.5%) were pedunculated. Pedunculated lesions were excluded in this study because in our preliminary analysis, DR by immunostaining for αSMA and desmin had no power to discriminate Group A from Group B . Among the non-pedunculated type, 21 (55.3%) were DR positive lesions and 17 (44.7%) were DR-negative. No statistical significance was found between the DR positive and negative groups with regard to age, gender, tumor size, tumor location and histological type (Table 1).
2.1.2. Relationship between Diagnosis of DR and the Depth of Invasion in Early CRCs
The immunohistochemical analysis for αSMA and desmin of biopsy specimens revealed that the DR-positive group was composed of 21 (100%) cases belonging to Group B, and the DR-negative group was composed of 14 (82.4%) Group A cases (p < 0.001) among the non-pedunculated type CRCs (Table 2). The calculated sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy of DR positivity to differentiate Group A from Group B were 87.5%, 100%, 100%, 82.4% and 92.1%, respectively.
Desmoplastic reaction (DR), which is characterized by stromal fibrosis of invasive carcinomas, is thought to start increasing when carcinoma cells have invaded beyond the muscularis mucosae [8,9]. On the other hand, Martin et al. reported that the dense fibroblastic reaction is capable of restraining the progression of tumor cells and plays a role in tumor regression . The differences in these articles may have arisen due to the complex crosstalk mechanisms between the carcinoma and stroma.
In the multicenter collaborative studies led by the Japanese Society for Cancer of the Colon and Rectum (JSCCR) [1,6], we previously demonstrated that the biopsy specimens from Group B were frequently evaluated as DR-positive lesions. These pathological examinations were performed on sections stained with H & E. Thus, these studies revealed that it is possible to predict SM depth by diagnosis of pretreatment biopsy specimens, especially in non-pedunculated, but not in pedunculated CRCs.
It is generally known that growth of myofibroblasts is affected not only by tumor progression but also by inflammatory or mechanical stimulation, and indeed, pedunculated colorectal tumors (such as pedunculated M CRC, Juvenile type polyp, Peutz-Jeghers type polyp and mucosal prolapse syndrome) tend to have abundant myofibroblasts around the muscularis mucosae, regardless of histological malignancy. In our former studies, we found that it was difficult to diagnose DR in some biopsy specimens from non-pedunculated CRCs that were stained with H&E. To resolve this problem, the present study was carried out to detect the presence of DR using biopsy specimens, immunostained for αSMA and desmin, and to determine whether or not the discrimination accuracy between Groups A and B could be improved.
In our retrospective study, the calculated sensitivity, specificity, PPV and NPV of DR positivity to differentiate Group A from Group B were 64.8%, 65.2%, 91.9% and 23.3%, respectively . Subsequently, in our prospective study, the calculated sensitivity, specificity, PPV and NPV of DR positivity to differentiate Group A from Group B were 68.6%, 92.0%, 94.6% and 59.0%, respectively . However, in this study, the calculated sensitivity, specificity, PPV and NPV of DR positivity to differentiate Group A from Group B were 87.5%, 100%, 100% and 82.4%, respectively. Thus, the sensitivity, specificity, PPV and NPV from the current study were markedly increased compared with the previously results. In particular, it was remarkable that DR-positive lesions were all Group B CRCs.
Although DR wasn’t detected in pretreatment biopsy specimens of the three cases in Group B, DR positivity was shown in the resected specimens from all of them. The endoscopic findings of them were all sessile. The mean tumor size of the three lesions was 20.7 mm (range, 20 to 22 mm), which was 7.7 mm greater than that of all 38 lesions. In retrospect, it seemed that inappropriate biopsies were performed in these 3 cases; inappropriate biopsies were defined as those taken at the edge of the tumor, but without the presence of SM2. Consequently, if the biopsies had included SM2 of the lesions, all Group B cases would have been accurately diagnosed with DR.
3. Experimental Section
3.1. Patients and Ethics
A total of 51 early CRCs in 49 patients, who had undergone surgical or endoscopic resection at Dokkyo University School of Medicine and its associated institutes between 1989 and 2004, were included in this study. They were classified endoscopically into pedunculated or non-pedunculated type as previously reported . Non-pedunculated CRCs were selected as subjects of this study. Patients with inflammatory bowel disease and familial adenomatous polyposis were excluded from the study. The study was approved by the relevant institutional ethics committee in JSCCR and all samples were collected with the patients’ consent.
For the ethics procedure, a linkable anonymizing method was used to ensure the study was conducted in a blinded manner. Samples used in this study were materials from biopsy or surgery obtained for diagnosis or treatment and not for research purposes. Participation in the present study did not increase medical disadvantage or risk for patients, and data were used strictly for analysis of information as part of therapeutic intervention.
3.2. Histology and Immunohistochemistry
Specimens were immediately fixed in a 10% buffered formalin solution. Endoscopic resection specimens were cut at 2 mm intervals and surgically resected tissues were cut along the axis at 2 to 4 mm intervals for sections to be stained with H & E. The depth of the invasion, which was measured according to the previous report [2,11] was examined in H & E stained specimens and the lesions were subsequently divided into two groups: A and B. The histological type of the adenocarcinomas was subclassified according to the grade of differentiation, and the predominant pattern .
The biopsy specimens were stained with H & E and immunostained for αSMA and desmin. Immunohistochemical staining for αSMA and desmin was performed with an EnVision kit (Dako, Carpinteria, CA, USA) as described previously . In brief, sections (4 μm thick) placed on silane-coated slides were deparaffinized, rehydrated, then placed in 0.01 M citrate buffer (pH 6.0) and treated by microwave heating (MI-77, Azumaya, Tokyo, Japan; 400 W, 95 °C) for 10 min to facilitate antigen retrieval. The slides were thereafter pretreated with 0.3% H2O2 in methanol for 20 min at room temperature to quench endogenous peroxidase activity. The sections were incubated with 1% bovine serum albumin in phosphate-buffered saline for 30 min, and then αSMA (clone 1A 4, Nichirei Biosciences, Tokyo, Japan) and anti-desmin (clone D33, DAKO, Denmark) mouse monoclonal antibodies for 60 min. Thereafter, the sections were incubated with polymer immunocomplexes for 60 min. Finally, the sections were incubated in 3,3′-diaminobenzidine tetrahydrochloride and then counterstained with Carrazzi’s hematoxylin.
3.3. Evaluation of Immunohistochemical Staining
Positive for DR in biopsy specimens was defined as αSMA-positive and desmin-negative stroma in the carcinoma. The vessel wall and nonspecific reaction were excluded from analysis. Representative micrographs of biopsy and resection specimens with DR are shown in Figure 1.
3.4. Statistical Analysis
Statistical analysis was done using the StatView J-5.0 program (SAS Institute Inc., Cary, NC, USA). Categorical analysis of variables was performed Chi-square test or Fisher’s exact test, as appropriate. For continuous variables, two-group comparisons were performed with the nonparametric two-sample Mann-Whitney U-test. All tests were two-tailed, with differences reported as significant if p < 0.05.
The detection of DR positivity in pretreatment biopsy specimens, immunostained for αSMA and desmin, is useful for discriminating Group A from Group B. The results suggest that the diagnostic accuracy for myofibroblasts, which are characterized by αSMA-positive expression and desmin negativity, is an important factor in evaluation of DR positivity in biopsy specimen stained with H & E.
This study was supported in part by the Japanese Society for Cancer of the Colon and Rectum, the Young Investigator Award from Dokkyo Medical University (#2012-12-1 to Kazuya Ohno) and a Grant-in-Aid from the Japan Society for the Promotion of Science (#24590429 to Hiroyuki Mitomi and #23590410 to Takahiro Fujimori). The authors greatly thank C. Matsuyama, A. Shimizu, T. Ono, M. Katayama, N. Nagashima, S. Kidate and A. Kikuchi (Department of Surgical and Molecular Pathology, Dokkyo Medical University) for their excellent technical and secretarial assistance.
Conflict of Interest
The authors declare no conflict of interest.
- Kimura, R.; Fujimori, T.; Ichikawa, K.; Ajioka, Y.; Ueno, H.; Ohkura, Y.; Kashida, H.; Togashi, K.; Yao, T.; Wada, R.; et al. Desmoplastic reaction in biopsy specimens of early colorectal cancer: A Japanese prospective multicenter study. Pathol. Int 2012, 62, 525–531. [Google Scholar]
- Kitajima, K.; Fujimori, T.; Fujii, S.; Takeda, J.; Ohkura, Y.; Kawamata, H.; Kumamoto, T.; Ishiguro, S.; Kato, Y.; Shimoda, T.; et al. Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: A Japanese collaborative study. J. Gastroenterol 2004, 39, 534–543. [Google Scholar]
- Fujimori, T.; Kawamata, H.; Kashida, H. Precancerous lesions of the colorectum. J. Gastroenterol 2001, 36, 587–594. [Google Scholar]
- Matsuda, T.; Fukuzawa, M.; Uraoka, T.; Nishi, M.; Yamaguchi, Y.; Kobayashi, N.; Ikematsu, H.; Saito, Y.; Nakajima, T.; Fujii, T.; et al. Risk of lymph node metastasis in patients with pedunculated type early invasive colorectal cancer: A retrospective multicenter study. Cancer Sci 2011, 102, 1693–1697. [Google Scholar]
- Watanabe, T.; Itabashi, M.; Shimada, Y.; Tanaka, S.; Ito, Y.; Ajioka, Y.; Hamaguchi, T.; Hyodo, I.; Igarashi, M.; Ishida, H.; et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int. J. Clin. Oncol 2012, 17, 1–29. [Google Scholar]
- Hirose, M.; Fukui, H.; Igarashi, Y.; Fujimori, Y.; Katake, Y.; Sekikawa, A.; Ichikawa, K.; Tomita, S.; Imura, J.; Ajioka, Y.; et al. Detection of desmoplastic reaction in biopsy specimens is useful for predicting the depth of invasion of early colorectal cancer: A Japanese collaborative study. J. Gastroenterol 2010, 45, 1212–1218. [Google Scholar]
- Fujimori, T. Unpublished observation; Dokkyo Medical University: Japan, 2013. [Google Scholar]
- Halvorsen, T.B.; Seim, E. Association between invasiveness, inflammatory reaction, desmoplasia and survival in colorectal cancer. J. Clin. Pathol 1989, 42, 162–166. [Google Scholar]
- Tsujino, T.; Seshimo, I.; Yamamoto, H.; Ngan, C.Y.; Ezumi, K.; Takemasa, I.; Ikeda, M.; Sekimoto, M.; Matsuura, N.; Monden, M. Stromal myofibroblasts predict disease recurrence for colorectal cancer. Clin. Cancer Res 2007, 13, 2082–2090. [Google Scholar]
- Martin, M.; Pujuguet, P.; Martin, F. Role of stromal myofibroblasts infiltrating colon cancer in tumor invasion. Path. Res. Pract 1996, 192, 708–717. [Google Scholar]
- Japanese Society for Cancer of the Colon and Rectum. Japanese Classification of Colorectal Carcinoma, 2nd ed; Kanehara & Co., Ltd: Tokyo, Japan, 2009.
- Fukui, H.; Fujii, S.; Takeda, J.; Kayahara, T.; Sekikawa, A.; Nanakin, A.; Suzuki, K.; Hisatsune, H.; Seno, H.; Sawada, M.; et al. Expression of Reg Iα protein in human gastric cancers. Digestion 2004, 69, 177–184. [Google Scholar]
|Table 1. Clinicopathological characteristics of 38 patients with non-pedunculated type of early colorectal carcinomas (CRCs).|
|Number of lesion, n (%)||21 (55.3)||17 (44.7)||38 (100)|
|Mean (range)||60.2 (39–79)||67.4 (53–79)||63.4 (39–79)||NS|
|Male/Female, n (%)||12 (57)/9 (43)||12 (71)/5 (29)||24(63)/14 (37)||NS|
|Tumor Size (mm)|
|Median (range)||20 (5–35)||13 (4–35)||16.5 (4–35)||NS|
|Location, n (%)|
|Rectum||4 (19.0)||5 (29.4)||9 (23.7)||NS|
|Sigmoid||6 (28.6)||6 (35.3)||12 (31.6)|
|Descending||2 (9.5)||1 (5.9)||3 (7.9)|
|Transverse||4 (19.0)||5 (29.4)||9 (23.7)|
|Ascending||4 (19.0)||0 (0)||4 (10.5)|
|Cecum||1 (4.9)||0 (0)||1 (2.6)|
|Histological type, n (%)||NS|
|Well-differentiated||14 (67)||15 (88)||29 (76)|
|Moderately-differentiated||7 (33)||2 (12)||9 (24)|
DR, desmoplastic reaction; NS, not significant.
|Table 2. Relationship between DR and the depth of invasion (Group A, B) of non-pedunculated early CRCs.|
|DR||Group A||Group B||p-value|
DR, desmoplastic reaction.
© 2013 by the authors; licensee MDPI, Basel, Switzerland This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).